FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110209907> ?p ?o ?g. }

• W2110209907 endingPage "323" @default.
• W2110209907 startingPage "315" @default.
• W2110209907 abstract "Abstract Purpose: We have shown that DNA methylation of the PITX2 gene predicts risk of distant recurrence in steroid hormone receptor-positive, node-negative breast cancer. Here, we present results from a multicenter study investigating whether PITX2 and other candidate DNA methylation markers predict outcome in node-positive, estrogen receptor-positive, HER-2-negative breast cancer patients who received adjuvant anthracycline-based chemotherapy. Experimental Design: Using a microarray platform, we analyzed DNA methylation in regulatory regions of PITX2 and 60 additional candidate genes in 241 breast cancer specimens. Using Cox regression analysis, we assessed the predictive power of the individual marker/marker panel candidates. Clinical endpoints were time to distant metastasis, disease-free survival, and overall survival. A nested bootstrap/cross-validation strategy was applied to identify and validate marker panels. Results: DNA methylation of PITX2 and 14 other genes was correlated with clinical outcome. In multivariate models, each methylation marker added significant information to established clinical factors. A four-marker panel including PITX2, BMP4, FGF4, and C20orf55 was identified that resulted in improvement of outcome prediction compared with PITX2 alone. Conclusions: This study provides further evidence for the PITX2 biomarker, which has now been successfully confirmed to predict outcome among different breast cancer patient populations. We further identify new DNA methylation biomarkers, three of which can be combined into a panel with PITX2 to increase the outcome prediction performance in our anthracycline-treated primary breast cancer population. Our results show that a well-defined panel of DNA methylation markers enables outcome prediction in lymph node-positive, HER-2-negative breast cancer patients treated with anthracycline-based chemotherapy." @default.
• W2110209907 created "2016-06-24" @default.
• W2110209907 creator A5009242861 @default.
• W2110209907 creator A5012726033 @default.
• W2110209907 creator A5021597189 @default.
• W2110209907 creator A5023638355 @default.
• W2110209907 creator A5026604806 @default.
• W2110209907 creator A5027231412 @default.
• W2110209907 creator A5027964010 @default.
• W2110209907 creator A5028752254 @default.
• W2110209907 creator A5031592069 @default.
• W2110209907 creator A5033446747 @default.
• W2110209907 creator A5044085548 @default.
• W2110209907 creator A5049939786 @default.
• W2110209907 creator A5060909413 @default.
• W2110209907 creator A5066680524 @default.
• W2110209907 creator A5066926133 @default.
• W2110209907 creator A5084106918 @default.
• W2110209907 date "2008-12-31" @default.
• W2110209907 modified "2023-10-15" @default.
• W2110209907 title "DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy" @default.
• W2110209907 cites W1755052449 @default.
• W2110209907 cites W1967089098 @default.
• W2110209907 cites W1981442074 @default.
• W2110209907 cites W1981885216 @default.
• W2110209907 cites W1987254926 @default.
• W2110209907 cites W2010652203 @default.
• W2110209907 cites W2013039468 @default.
• W2110209907 cites W2014090721 @default.
• W2110209907 cites W2028239334 @default.
• W2110209907 cites W2040257851 @default.
• W2110209907 cites W2049961256 @default.
• W2110209907 cites W2054823635 @default.
• W2110209907 cites W2063978763 @default.
• W2110209907 cites W2070605698 @default.
• W2110209907 cites W2075213874 @default.
• W2110209907 cites W2078881615 @default.
• W2110209907 cites W2092931112 @default.
• W2110209907 cites W2096287539 @default.
• W2110209907 cites W2105981176 @default.
• W2110209907 cites W2110065044 @default.
• W2110209907 cites W2111967651 @default.
• W2110209907 cites W2121656289 @default.
• W2110209907 cites W2122598723 @default.
• W2110209907 cites W2129682511 @default.
• W2110209907 cites W2136795378 @default.
• W2110209907 cites W2142503898 @default.
• W2110209907 cites W2145788892 @default.
• W2110209907 cites W2156365329 @default.
• W2110209907 cites W2156604663 @default.
• W2110209907 cites W2158143138 @default.
• W2110209907 cites W2166396916 @default.
• W2110209907 cites W2167238270 @default.
• W2110209907 cites W2328946792 @default.
• W2110209907 cites W3175417087 @default.
• W2110209907 cites W4240611546 @default.
• W2110209907 cites W4243667708 @default.
• W2110209907 cites W4293241248 @default.
• W2110209907 cites W957302832 @default.
• W2110209907 doi "https://doi.org/10.1158/1078-0432.ccr-08-0166" @default.
• W2110209907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19118060" @default.
• W2110209907 hasPublicationYear "2008" @default.
• W2110209907 type Work @default.
• W2110209907 sameAs 2110209907 @default.
• W2110209907 citedByCount "87" @default.
• W2110209907 countsByYear W21102099072012 @default.
• W2110209907 countsByYear W21102099072013 @default.
• W2110209907 countsByYear W21102099072014 @default.
• W2110209907 countsByYear W21102099072015 @default.
• W2110209907 countsByYear W21102099072016 @default.
• W2110209907 countsByYear W21102099072017 @default.
• W2110209907 countsByYear W21102099072018 @default.
• W2110209907 countsByYear W21102099072019 @default.
• W2110209907 countsByYear W21102099072020 @default.
• W2110209907 countsByYear W21102099072021 @default.
• W2110209907 countsByYear W21102099072023 @default.
• W2110209907 crossrefType "journal-article" @default.
• W2110209907 hasAuthorship W2110209907A5009242861 @default.
• W2110209907 hasAuthorship W2110209907A5012726033 @default.
• W2110209907 hasAuthorship W2110209907A5021597189 @default.
• W2110209907 hasAuthorship W2110209907A5023638355 @default.
• W2110209907 hasAuthorship W2110209907A5026604806 @default.
• W2110209907 hasAuthorship W2110209907A5027231412 @default.
• W2110209907 hasAuthorship W2110209907A5027964010 @default.
• W2110209907 hasAuthorship W2110209907A5028752254 @default.
• W2110209907 hasAuthorship W2110209907A5031592069 @default.
• W2110209907 hasAuthorship W2110209907A5033446747 @default.
• W2110209907 hasAuthorship W2110209907A5044085548 @default.
• W2110209907 hasAuthorship W2110209907A5049939786 @default.
• W2110209907 hasAuthorship W2110209907A5060909413 @default.
• W2110209907 hasAuthorship W2110209907A5066680524 @default.
• W2110209907 hasAuthorship W2110209907A5066926133 @default.
• W2110209907 hasAuthorship W2110209907A5084106918 @default.
• W2110209907 hasBestOaLocation W21102099071 @default.
• W2110209907 hasConcept C104317684 @default.
• W2110209907 hasConcept C121608353 @default.
• W2110209907 hasConcept C126322002 @default.
• W2110209907 hasConcept C143998085 @default.

• next